\documentclass{beamer}
\usepackage{tikz}
\usepackage{graphicx}
\usepackage{booktabs}
%\graphicspath{F:/antimicrobial resistance/Simon/thorax2/FES2014/R_code}
\usepackage{hyperref}

\definecolor{pheMainRed}{cmyk}{0, 1, 0.61, 0.43}
\definecolor{pheMainBlue}{cmyk}{0.9, 0, 0.49, 0}
\defbeamertemplate*{title page}{customised}[1][]{%

%-----------------------------------------------------------
% Redefine title page
%-----------------------------------------------------------
\begin{tikzpicture}[remember picture,overlay]
\fill[pheMainRed]
([yshift=60pt]current page.west) rectangle (current page.south east);
%\draw([yshift=60pt]current page.west) circle (0.5cm);
\fill[pheMainBlue]
([yshift=60pt]current page.west) rectangle ([yshift=65pt]current page.east);
\node[anchor=west]
	at ([yshift=-5pt]current page.west) (title)
%	(title)
	{\parbox[t]{\linewidth}{\raggedright\usebeamerfont{title}\usebeamercolor[fg]{title}\Large\inserttitle}};
\node[anchor=west]
	at ([yshift=50pt]current page.south west) (author)
	{\parbox[t]{\linewidth}{\raggedright\usebeamerfont{title}\usebeamercolor[fg]{title}\normalsize\insertauthor}};	
\node[anchor=west]
	at ([yshift=25pt]current page.south west) (date)
	{\parbox[t]{\linewidth}{\raggedright\usebeamerfont{title}\usebeamercolor[fg]{title}\normalsize\insertdate\\Field Epidemiology Scientific Meeting}};	
\node[anchor=south west] 
  at ([yshift=90pt]current page.west) (logo)
  {\parbox[t]{.19\paperwidth}{\raggedleft%
    \usebeamercolor[fg]{titlegraphic}\inserttitlegraphic}};
\end{tikzpicture}
}
%-----------------------------------------------------------
% Redefine footer
%-----------------------------------------------------------
\makeatother
\setbeamertemplate{footline}
{
  \leavevmode%
  \hbox{%
  \begin{beamercolorbox}[wd=.2\paperwidth,ht=2.25ex,dp=1ex,center]{footBox}%
%    \usebeamerfont{author in head/foot}\insertshortauthor
    \insertframenumber{} / \inserttotalframenumber\hspace*{1ex}
  \end{beamercolorbox}%
  \begin{beamercolorbox}[wd=.8\paperwidth,ht=2.25ex,dp=1ex,center]{footBox}%
    \usebeamerfont{title in head/foot}\insertshorttitle\hspace*{3em}

  \end{beamercolorbox}}%
  \vskip0pt%
}

%-----------------------------------------------------------
% Redefine colours
%-----------------------------------------------------------
\setbeamercolor{footBox}{fg=white, bg=pheMainRed}
\setbeamercolor{title}{fg=white}
\setbeamercolor{frametitle}{fg=pheMainBlue}
\setbeamercolor{bibliography entry author}{fg=pheMainBlue}
\setbeamercolor{bibliography entry location}{fg=white!30!pheMainBlue}
\setbeamercolor{itemize item}{fg=pheMainBlue}
\setbeamercolor{itemize subitem}{fg=pheMainBlue}
\setbeamercolor{itemize subsubitem}{fg=pheMainBlue}
\setbeamercolor{description item}{fg=pheMainBlue}

%\setbeamercolor{title}{fg=pheMainRed}
\titlegraphic{\includegraphics[width=2cm]{phe_logo}}
\setbeamercolor{titleBox}{fg=white, bg=pheMainRed}
\hypersetup{urlcolor = pheMainBlue} % Set colour of URLs

\setbeamercovered{transparent}

%-----------------------------------------------------------
% Title and authors
%-----------------------------------------------------------
\title[Trends in susceptibility of \textit{H. influenzae}, \textit{S. pneumoniae} and \textit{S. aureus} from respiratory isolates]{Trends in the antibiotic susceptibilities of \textit{Haemophilus influenzae}, \textit{Streptococcus pneumoniae} and \textit{Staphylococcus aureus} from respiratory isolates in England, Wales and Northern Ireland, 2008 - 2013}
\subtitle{}
\author{Simon Thelwall}


\date{03 March 2014}

%-----------------------------------------------------------
% Start the actual document
%-----------------------------------------------------------

\begin{document}
{ % remove footline from title page. 
\setbeamertemplate{footline}{} 
\begin{frame}
\maketitle
\end{frame}
}
\addtocounter{framenumber}{-1}

\begin{frame}{Background - 1}
Resistance in organisms likely to cause secondary infections in the event of an influenza pandemic. 
\begin{thebibliography}{Blackburn et al, 2011}
\bibitem{Blackburn2011}
{\footnotesize
Blackburn, R. M., Henderson, K. L., Lillie, M., Sheridan, E., George, R. C., Deas, A. H. B., \& Johnson, A. P. (2011). 
\newblock Empirical treatment of influenza-associated pneumonia in primary care: a descriptive study of the antimicrobial susceptibility of lower respiratory tract bacteria (England, Wales and Northern Ireland, January 2007-March 2010). 
\newblock Thorax, 66(5), 389–95. doi:10.1136/thx.2010.134643
}
\end{thebibliography}
\end{frame}

\begin{frame}{Background - 2}
Recommended empiric antibiotic for community management of CAP in adults:
\begin{itemize}
\item Amoxicillin 
\item Doxycycline or clarithromycin for penicillin hypersensitive patients
\item On failure of initial empiric therapy: macrolide
\end{itemize}
\begin{thebibliography}{Lim et al, 2009}
\bibitem{Lim2009}
{\footnotesize
Lim, W. S., Baudouin, S. V, George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., … Woodhead, M. A. (2009). 
\newblock BTS guidelines for the management of community acquired pneumonia in adults: update 2009. 
\newblock Thorax, 64 Suppl 3(October), iii1–55. doi:10.1136/thx.2009.121434
}
\end{thebibliography}
\end{frame}

\begin{frame}{Methods}
\begin{description}
\item[Data source]LabBase - voluntary laboratory surveillance of clinically relevant infections. 
\begin{itemize}
\item Respiratory samples: sputum, trachea, broncheoles or alveolar lavage.
\item January 2008 - June 2013.
\item hospital outpatient or GP patients.
\end{itemize}
\pause \item[Resistance] Isolate reported as intermediate or resistant. \hfill \\
Where multiple sensitivities reported, resistant result took precendence.
\pause \item[Analysis] R version 3.0.2
\begin{itemize}
\pause \item Linear regression for trend in number of isolates reported.
\pause \item Poisson regression for annual change in number of resistant isolates reported.
\begin{itemize}
\item Adjusted for age, sex, calendar quarter and region.
\end{itemize}
\end{itemize}
\end{description}
\end{frame}
\section{Results}
\begin{frame}{Results - summary figures}
\begin{itemize}
\item 180 499 isolates
\begin{itemize}
\item 65 \% \textit{H. influenzae}
\item 18 \% \textit{S. aureus}
\item 17 \% \textit{S. pneumoniae}
\end{itemize}
\pause \item 142 labs
\pause \item 96 \% from sputum
\pause \item 70 \% from GP patients
\end{itemize}
\end{frame}

\begin{frame}{Results - Age structure of patients providing respiratory isolates, by organism. England, Wales and Northern Ireland. 2008 - June 2013}
\begin{figure}
\includegraphics[width = \textwidth]{age_fig}
%\caption{Age structure for patients providing respiratory isolates, by organism. England, Wales and Northern Ireland. 2008 - June 2013.}
\end{figure}
\end{frame}

\begin{frame}{Results - Trend in number of respiratory isolates, by organism. England, Wales and Northern Ireland. 2008 - June 2013}
\begin{figure}
\centering
\includegraphics[width = 0.85\textwidth]{trend_isolates}
%\includegraphics[height = \textheight]{trend_isolates}
%\includegraphics[scale=0.75, keepaspectratio = true]{trend_isolates}
\end{figure}
\end{frame}

\begin{frame}{Results - Trend in proportion of respiratory isolates tested, by organism. England, Wales and Northern Ireland. 2008 - June 2013}
\begin{figure}
\includegraphics[width = 0.85\textwidth]{trend_testing}
\end{figure}
\end{frame}

\begin{frame}{Results - Trend in resistance of respiratory isolates tested, by organism. England, Wales and Northern Ireland. 2008 - June 2013} 
\begin{figure}
\includegraphics[width = 0.85\textwidth]{trend_resistance}
\end{figure}
\end{frame}

\begin{frame}{Results - Incident rate ratios for annual change in resistance. England, Wales and Northern Ireland. 2008 - June 2013}
% The following is an enormous mess but gets the job done. 
\begin{table}
   \centering
   \tiny%\addtolength{\tabcolsep}{-5pt}
   \begin{tabular}{rrlll}
  \hline
 &  & \multicolumn{3}{c}{Organism}\\
  \cline{3-5}
Antibiotic & \shortstack{Age \\group} & \textit{H. influenzae} & \textit{S. aureus} & \textit{S. pneumoniae} \\ 
  \midrule
\onslide<1>{ \shortstack{Ampicillin/\\amoxicillin}} & \onslide<1>{ - }& \onslide<1>{ 1.03 (1.02-1.03)} & \onslide<1>{ 1.01 (1.00-1.03)} & \onslide<1>{ 1.12 (1.05-1.20)} \\ 
\onslide<2>{ Clarithromycin} & \onslide<2>{$<45$ }& \onslide<2>{1.01 (1.00-1.01)} & \onslide<2>{1.00 (0.95-1.06)} & \onslide<2>{1.06 (0.96-1.17)}\\ 
\onslide<2>{  }& \onslide<2>{ 45-64} & \onslide<2>{ 1.01 (1.00-1.01)} & \onslide<2>{ 1.01 (0.95-1.07)} & \onslide<2>{ 1.10 (1.03-1.16)} \\ 
\onslide<2>{  }& \onslide<2>{ 65-74} & \onslide<2>{ 1.00 (1.00-1.01)} & \onslide<2>{ 0.95 (0.89-1.01)} & \onslide<2>{ 1.11 (1.04-1.18)} \\ 
\onslide<2>{  }& \onslide<2>{ $\geq 75$} & \onslide<2>{ 1.01 (1.00-1.01)} & \onslide<2>{ 1.05 (0.99-1.12)} & \onslide<2>{ 1.09 (1.01-1.17)} \\ 
\onslide<2>{  }& \onslide<2>{ Unknown} & \onslide<2>{ 1.00 (0.91-1.09)} & \onslide<2>{ 0.97 (0.09-10.75)} & \onslide<2>{ 0.99 (0.70-1.40)} \\ 
\onslide<3>{ Doxycycline} & \onslide<3>{$<45$} & \onslide<3>{0.80 (0.65-0.98)} & \onslide<3>{1.36 (1.13-1.63)} & \onslide<3>{1.03 (0.81-1.31)} \\ 
\onslide<3>{  }& \onslide<3>{45-64} & \onslide<3>{0.85 (0.71-1.01) }& \onslide<3>{1.01 (0.85-1.20)} & \onslide<3>{1.14 (1.01-1.28)} \\ 
\onslide<3>{  }& \onslide<3>{65-74} & \onslide<3>{0.86 (0.69-1.07) }& \onslide<3>{1.18 (0.90-1.55)} & \onslide<3>{1.34 (1.18-1.52)} \\ 
\onslide<3>{  }& \onslide<3>{$\geq 75$} & \onslide<3>{0.90 (0.71-1.15)} & \onslide<3>{1.14 (0.90-1.42)} & \onslide<3>{1.10 (0.94-1.29)} \\ 
\onslide<3>{  }& \onslide<3>{Unknown} & \onslide<3>{0.93 (0.57-1.54)} & \onslide<3>{0.95 (0.08-10.74)} & \onslide<3>{- }\\ 
\bottomrule  
\end{tabular}
%   \caption{Incident rate ratios for annual change in susceptibility to recommended antimicrobials, England, Wales and Northern Ireland 2008-2013.
%   Adjusted for calendar quarter, laboratory region, specimen source, male sex and patient age.}
%   \label{tab:table1}
   \end{table} 
\end{frame}

\begin{frame}{Trend in resistance to both ampicillin/amoxicillin and any macrolide. England, Wales and Northern Ireland. 2008 - June 2013}
\begin{figure}
\includegraphics[width = \textwidth]{trend_multi}
\end{figure}
\end{frame}

\begin{frame}{Incident rate ratios for resistance to both ampicillin/amoxicillin and any macrolide. England, Wales and Northern Ireland. 2008 - June 2013.}
% latex table generated in R 3.0.2 by xtable 1.7-1 package
% Mon Feb 17 15:49:47 2014
\begin{table}[ht]
\centering
\begin{tabular}{lrr}
  \toprule
Organism & Incident rate ratio & 95 \% confidence interval \\ 
  \midrule
\textit{H. influenzae} & 1.04 & (1.03 - 1.06) \\ 
  \textit{S. aureus} & 0.98 & (0.93 - 1.03) \\ 
  \textit{S. pneumoniae} & 1.16 & (1.07 - 1.25) \\ 
   \bottomrule
\end{tabular}
\end{table}
\end{frame}


\section{Conclusions}
\begin{frame}{Conclusions}
\begin{itemize}
\item Increasing numbers of isolates being reported. 
\pause \item Strong increases in resistance to ampicillin/amoxicillin among \textit{S. pneumoniae} and to doxycycline among \textit{S. aureus} and \textit{S. pneumoniae}. 
\pause \item Resistance to first and second line treatments increasing in \textit{H. influenzae} and \textit{S. pneumoniae}. 
\end{itemize}
\end{frame}

\begin{frame}{End matter}
\begin{description}
\item[Acknowledgements]Rebecca Guy, Berit Muller-Pebody, Alan Johnson. 
Department of Healthcare Associated Infections and Antimicrobial Resistance, Centre for Disease Surveillance and Control, Public Health England.

Macey Murray. Centre for Paediatric Pharmacy Research, Department of Practice and Policy, UCL School of Pharmacy, University College London

Mike Sharland. Paediatric Infectious Diseases Unit, St George's Hospital NHS Trust, London, UK
\item[Code] \url{https://github.com/simonthelwall/}
\item[Email] \href{mailto:simon.thelwall@phe.gov.uk}{\nolinkurl{simon.thelwall@phe.gov.uk} }
\end{description}
\end{frame}

\end{document}
